MARKET OVERVIEW

The global botanicals and acupuncture market was valued at USD 90.16 Billion in 2024 and is forecasted to reach USD 333.94 Billion by 2033, exhibiting a CAGR of 14.41% during the 2025-2033 forecast period. Europe dominates with over 34.5% market share in 2024, driven by demand for natural therapies and preventive healthcare. Botanicals and Acupuncture Market growth is fueled by rising consumer preference for holistic, sustainable health solutions.

STUDY ASSUMPTION YEARS

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

BOTANICALS AND ACUPUNCTURE MARKET KEY TAKEAWAYS

• Current Market Size: USD 90.16 Billion in 2024
• CAGR: 14.41%
• Forecast Period: 2025-2033
• Europe holds the largest market share of over 34.5% in 2024, driven by consumer interest in natural health solutions and a robust healthcare system.
• Increasing consumer demand for natural, non-pharmaceutical treatments is a key growth driver.
• Regulatory support, such as FDA oversight in the U.S. and EMA approvals in Europe, enhances market credibility.
• The U.S. dominated North America with 87.9% market share, fueled by innovation and integration of acupuncture into mainstream healthcare.
• Rising prevalence of chronic conditions and demand for holistic wellness fuels adoption globally.

Sample Request Link: https://www.imarcgroup.com/botanicals-acupuncture-market/requestsample

MARKET GROWTH FACTORS

The main influencer on the market of botanicals and acupuncture remains to be the increasing need of consumers for natural and alternative healthcare solutions. The market has gained an advantage through people's choice of non-pharmaceutical products and treatments over the conventional ones for chronic conditions, stress, and wellness. Such consumers perceive botanical products and acupuncture treatments as safe, efficient and having minimal side effects. The trend is particularly strong among health-conscious people who want to give a holistic health approach a try. In addition, the Scientific Association for Botanical Education and Research (SABER) has proclaimed its readiness to develop the botanical field through methods that guarantee safety and are based on prior evidence in the first month of 2025.

Furthermore, the demand for market expansion is provided by the worldwide rise in the number of patients suffering from chronic diseases like chronic pain, stress-related disorders, and mental health issues. The number of adults with more than one chronic disease is around 33% which is a good number to encourage the utilization of natural treatments and alternative medicines to get rid of the condition. Patients with different types of chronic pain are offered various herbal remedies from botanicals for pain and stress management while they can also choose acupuncture as it helps in pain relief and therefore improves well-being making it a non-pharmaceutical option that is easy to take.

One more reason for the growth is the continuous and increasing number of research and clinical studies on botanicals and acupuncture worldwide. A report from the World Health Organization (WHO) revealed that clinical trials registered on the International Clinical Trials Registry Platform (ICTRP) reached their highest number in 2021 which indicates that safety and efficacy evaluation is progressing. Healthcare practitioners are becoming increasingly willing to incorporate these therapies into their treatment protocols and the positive outcomes of research are contributing to this trend. The increase of clinical trials in Europe, America, and the Western Pacific indicates the global commitment to research is very strong.

MARKET SEGMENTATION

Analysis by Intervention:

• Botanicals: This largest segment in 2024 (68.8% market share) includes herbal medicine and plant-derived substances used therapeutically. Products comprise herbal remedies, dietary supplements, teas, tinctures, essential oils, and botanical-based items. It also encompasses services by herbalists, naturopathic practitioners, and holistic providers specializing in botanical treatments.
• Ayurveda
• Naturopathy
• Homeopathy
• Acupuncture

Analysis by Distribution Method:

• Direct Sales: Leading with 73.9% market share in 2024, this method involves traditional brick-and-mortar retail, wellness centers, herbal shops, and acupuncture clinics where consumers directly purchase products or services.
• E-sales
• Distance
• Correspondence

REGIONAL INSIGHTS

Europe is the dominant region in botanicals and acupuncture by market share, holding over 34.5% in 2024. This leadership is driven by increased consumer interest in natural and holistic health solutions, a well-established healthcare system, demand for organic and sustainable products, and regulatory support such as EMA approvals. The region's emphasis on preventive healthcare and integration of acupuncture into mainstream physical therapy and wellness clinics further fuels growth.

RECENT DEVELOPMENTS & NEWS

• February 2025: Herbaria-Modern Botanicals became the first Indian skincare brand to showcase at NYC's New York Fashion Week, featuring zero-plastic botanical formulations and serving as backstage skincare partner.
• January 2025: Loyalist expanded health programs in Ontario with Pharmacy Technician and Acupuncture courses to train more healthcare practitioners.
• January 2025: Blue Toad Botanicals introduced "You've Got Some NERVE," a botanical preparation with extracts like Vanizem and proprietary blends, marketed by PLT Health Solutions.
• October 2024: Champneys day spas in the UK launched auricular acupuncture for weight management targeting hormones linked with hunger and metabolism.
• September 2024: Evonik introduced botanical actives CapilAcid and Oleobiota for sustainable beauty, aimed at antioxidant protection and sebum regulation, respectively.

KEY PLAYERS

• ARC Acupuncture & Physical Therapy
• Ayush Ayurvedic Pte Ltd
• Chiropuncture, Inc.
• Herb Pharm, LLC
• Herbal Hills
• LKK Health Products Group Ltd. (Lee Kum Kee Group)
• Modern Acupuncture
• NatureKue, Inc.
• Nordic Nutraceuticals UK Ltd
• Sheng Chang Pharmaceutical Company

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

ABOUT US

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

CONTACT US

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302